{"schema_version":"secwatch.filing_event.v1","accession":"0001615219-25-000119","form_type":"8-K","ticker":"DCOY","cik":"0001615219","company_name":"Decoy Therapeutics Inc.","filed_at":"2025-08-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.488583+00:00","generated_at":"2026-05-17T09:42:44.156297+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Salarius Pharmaceuticals receives Nasdaq extension to regain equity compliance by Oct 20, 2025","bullets":["Nasdaq Hearings Panel granted Salarius until October 20, 2025 to comply with the Equity Standard (Rule 5550(b)(1)).","Salarius effected a 1-for-15 reverse stock split on August 15, 2025, targeting compliance with the $1.00 Minimum Bid Price by August 29, 2025.","Previously received a Delisting Notice on April 23, 2025 for noncompliance with the Minimum Bid Price Requirement.","The extension follows prior milestones, including a previous extension granted on July 28, 2025 for compliance by August 12 (equity) and August 29 (bid price)."],"urls":{"canonical":"https://secwatch.observer/filing/0001615219-25-000119","json":"https://secwatch.observer/filing/0001615219-25-000119.json","markdown":"https://secwatch.observer/filing/0001615219-25-000119.md","text":"https://secwatch.observer/filing/0001615219-25-000119.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1615219/000161521925000119/0001615219-25-000119-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1615219/000161521925000119/flks-20250827.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-17T09:42:44.156297+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}